Showing 19,381 - 19,400 results of 42,148 for search '(( a point decrease ) OR ( 50 ((((we decrease) OR (nn decrease))) OR (a decrease)) ))', query time: 1.18s Refine Results
  1. 19381

    Image_3_Global, Regional, and National Burden of Myocarditis From 1990 to 2017: A Systematic Analysis Based on the Global Burden of Disease Study 2017.TIF by Xiqiang Wang (5955647)

    Published 2021
    “…</p><p>Results: The incidence cases of myocarditis in 2017 was 3,071,000, with a 59.6% increase from 1990, while the age-standardized incidence rate (ASIR) was slightly decreased. …”
  2. 19382

    The method presented in this paper for quickly identifying a network’s MIB using spectral clustering makes it possible to quickly measure integrated information in large brain netw... by Daniel Toker (6311834)

    Published 2019
    “…Following Watts and Strogatz [<a href="http://www.ploscompbiol.org/article/info:doi/10.1371/journal.pcbi.1006807#pcbi.1006807.ref053" target="_blank">53</a>], we varied <i>p</i> on a log-scale between 0.001 and 0.1; to explore the full parameter space, we also linearly varied <i>p</i> between 0.1 and 1. …”
  3. 19383
  4. 19384
  5. 19385
  6. 19386

    DataSheet_1_Effectiveness, safety and pharmacokinetics of Polo-like kinase 1 inhibitors in tumor therapy: A systematic review and meta-analysis.docx by Xiao Wei (44054)

    Published 2023
    “…Rigosertib (ON 01910.Na) was associated with a decreased risk of AEs in digestive system (ES, 0.103; 95% CIs, 0.059-0.147), but BI 2536 and Volasertib (BI 6727) increased risk of AEs in blood system (ES, 0.399; 95% CIs, 0.294-0.504). …”
  7. 19387

    M-TUBE is a fabrication-free, microfluidics tubing-based bacterial electroporation device that is simple to assemble and exhibits higher electroporation efficiency than cuvettes. by Po-Hsun Huang (183737)

    Published 2022
    “…Transformation was dependent on the electric field. For M-TUBE devices, a voltage of ±2.50 kV (AC field) was applied, which results in an electric field of 8.33 kV/cm. …”
  8. 19388

    DataSheet_2_Effectiveness, safety and pharmacokinetics of Polo-like kinase 1 inhibitors in tumor therapy: A systematic review and meta-analysis.pdf by Xiao Wei (44054)

    Published 2023
    “…Rigosertib (ON 01910.Na) was associated with a decreased risk of AEs in digestive system (ES, 0.103; 95% CIs, 0.059-0.147), but BI 2536 and Volasertib (BI 6727) increased risk of AEs in blood system (ES, 0.399; 95% CIs, 0.294-0.504). …”
  9. 19389
  10. 19390
  11. 19391
  12. 19392

    NK-DLI<sub>IL-2 stim</sub> but not NK-DLI<sub>unstim</sub> led to a considerable disappearance of NK cells from PB. by Claudia Brehm (197437)

    Published 2011
    “…Striped bars indicate estimated patient's PB volume and peripheral NK cell count at the time point of NK-DLI infusion. <u>Left graph</u> shows a mean 5.5-fold reduction of absolute NK cell count in the PB as early as 10 min post NK-DLI<sub>IL-2 stim</sub> compared to a 1.2-fold decrease for NK-DLI<sub>unstim</sub>. …”
  13. 19393

    Data Sheet 1_Development of a rapid fiber-detection system using artificial intelligence in phase-contrast microscope images of actual atmospheric samples.pdf by Yukiko Iida (21596408)

    Published 2025
    “…Additionally, since the counting process relies on visual fiber counting, analytical accuracy can be decreased due to factors such as analyst fatigue. Ambient air samples or air samples collected near demolition sites were observed and acquired using a phase contrast microscope. …”
  14. 19394
  15. 19395

    Data_Sheet_1_A randomized triple-blind controlled clinical trial evaluation of sitagliptin in the treatment of patients with non-alcoholic fatty liver diseases without diabetes.DOC... by Azam Doustmohammadian (8488608)

    Published 2022
    “…<p>The current study aimed to evaluate the efficacy of sitagliptin vs. placebo in treating non-alcoholic fatty liver disease (NAFLD). In a triple-blind randomized clinical trial, we assigned 120 eligible subjects with NAFLD to receive daily dosing of 50 mg sitagliptin (n = 60) or the placebo (n = 60) for 56 weeks and lifestyle modification in both groups. …”
  16. 19396

    Table_1_A Novel Natural Antimicrobial Can Reduce the in vitro and in vivo Pathogenicity of T6SS Positive Campylobacter jejuni and Campylobacter coli Chicken Isolates.DOCX by Filip Sima (5726201)

    Published 2018
    “…Furthermore, the reduced adhesion and invasion is associated with a significant decrease in bacterial motility of both isolates (p < 0.05–p < 0.001) in vitro. …”
  17. 19397

    Image_2_A Novel Natural Antimicrobial Can Reduce the in vitro and in vivo Pathogenicity of T6SS Positive Campylobacter jejuni and Campylobacter coli Chicken Isolates.JPEG by Filip Sima (5726201)

    Published 2018
    “…Furthermore, the reduced adhesion and invasion is associated with a significant decrease in bacterial motility of both isolates (p < 0.05–p < 0.001) in vitro. …”
  18. 19398

    Image_1_A Novel Natural Antimicrobial Can Reduce the in vitro and in vivo Pathogenicity of T6SS Positive Campylobacter jejuni and Campylobacter coli Chicken Isolates.JPEG by Filip Sima (5726201)

    Published 2018
    “…Furthermore, the reduced adhesion and invasion is associated with a significant decrease in bacterial motility of both isolates (p < 0.05–p < 0.001) in vitro. …”
  19. 19399
  20. 19400

    The impact of sublethal effects of fungal infection on mosquito feeding biology. by Penelope A. Hancock (223305)

    Published 2009
    “…Lines represent varying sublethal effects of fungal infection on mosquito feeding biology, including no sublethal effects (solid lines), a 25% decrease in the daily probability of finding a blood meal () and a 25% increase in the duration of the non-host-seeking stage () in fungal pathogen-infected mosquitoes (dashed lines), a 50% decrease in and a 50% increase in (dotted lines), and a 75% decrease in and a 75% increase in (dot-dashed lines). …”